Objectives: Cardiovascular risk can be predicted using lipid ratios such as the atherogenic index which is defined as the base 10 logarithm of the ratio of plasma triglyceride (TG) to high density lipoprotein cholesterol (HDL-C) -it is a useful prognostic parameter for guiding timely interventions and has also been employed as a predictor of cardiovascular risk. However, this is rarely used in the clinical practice in developing countries including Nigeria.
near normal LDL-C serum levels, there remains risk for future cardiovascular events. Hypertriglyceridemia has been identified as an independent cardiovascular risk factor (16, 17) . Hypertriglyceridemia is a proxy for atherogenic dyslipidemia (elevated triglyceride (TG)) and low high-density lipoprotein cholesterol) (17, 18) , a component of the metabolic syndrome and a known risk factor for CHD. Despite interaction with other lipids that might increase atherogenic risk and in-subject variation, elevated TG has been shown to be a good predictor of CHD in consideration of the HDL-C levels (18) and is used in clinical practice to predict atherosclerosis (18, 19) The lipid ratio log [TG/HDL-C] (atherogenic index) provides an alternative simple option for risk stratification. The use of this ratio is to reflect the balance between risk and protective lipoprotein forces (16) as well as acting as a correlate with LDL-C particle size (20) , LDL-phenotype B, and small HDL-C particles (4) . This ratio has also been evaluated as a prognostic tool in predicting CHD (4) and its predictive value far outweighs that of absolute lipid parameters (21, 22) as well as the TC /HDL ratio (22) given its strong correlation with lipoprotein particle size.
Nigeria bears a significant burden of hypertension and like other SSA countries is not adequately equipped with the necessary resources, expertise, and technology to manage the CVD sequelae. A rural population in Uganda reflected the dominant dyslipidemia pattern to be that of low serum HDL-C levels and a good proportion with hypertriglyceridemia (23) . W h e r e a s t h e r e a r e w e l l -r e c o g n i z e d recommendations on the use of serum LDL-C and TC for cardiovascular risk assessment, there is limited progress in addressing concerns with low serum HDL-C which may lead to underestimation of CHD risk (24) . Thus, assessment of atherogenic index provides a simple and reliable method for point of care risk assessment that can be done by healthcare providers even within hard-to-reach areas. The aim of this study was to assess the atherogenic risk profile using the atherogenic index among Hypertensive and Diabetic Patients in University of Ilorin Teaching Hospital.
METHODS

Study design and study setting
This was a hospital-based crosssectional study among registered patients with hypertension and diabetes attending outpatient clinics (General Outpatient Department and the
INTRODUCTION
The atherogenic index of plasma (AIP), is defined as the base 10 logarithm of the ratio of plasma triglyceride (TG) to high density lipoprotein cholesterol (HDL-C), and has been shown to be significant predictors for metabolic d i s t u r b a n c e s i n c l u d i n g d y s l i p i d e m i a , atherosclerosis, hypertension and cardiovascular diseases (CVD) (1, 2) . The term was proposed by Dobiasova and Frohlich to indicate that plasma atherogenicity was also a significant independent predictor of coronary heart disease (CHD) (3, 4) . It has been established that an AIP value of less than 0.11 is associated with low risk of CHD; the values between 0.11 to 0.24 and greater than 0.24 are associated with intermediate and high risks, respectively (5, 6) . Sensitivity of AIP has also been demonstrated in a cohort of patients undergoing coronary angiography, where it was found to be better than age, body mass index (BMI), waist circumference, type 2 diabetes mellitus (DM), blood pressure (BP), smoking, TG, total cholesterol (TC), low density lipoprotein (LDL-C), HDL-C, and TC/HDL-C, in predicting the possibility of positive findings (6, 7) .
In Western populations, dyslipidemia among patients with hypertension is a common finding. The prevalence of dyslipidemia coexisting with hypertension has been estimated at 15-24% (8, 9) . Over 40% of all newly diagnosed hypertensive patients have at least one lipid abnormality (10) . There is limited data on the burden of dyslipidemia among patients with hypertension in sub-Sahara Africa (SSA) whereas; hypertension and dyslipidemia are both identified as independent modifiable risk factors for CVD. Some studies have suggested that dyslipidemia may play a role in the development of hypertension via endothelial damage (11) and the risk for CVD is higher in the presence of both hypertension and dyslipidemia than by the individual disease entities (12) . In high income countries, strategies targeting the reduction of serum cholesterol levels provide the single most important benefit against CVD resulting from coronary heart disease (CHD) (13) . Presently, medical practice encourages risk stratification for all persons at risk of CHD including those with hypertension. This is advantageous for timely intervention in p r e v e n t i n g C H D a n d i t s ' s e q u e l a e . Cardiovascular risk assessment based solely on serum low density lipoprotein cholesterol (LDL-C) has been found to be inadequate (14, 15) and even in those on statin therapy with normal or The data was analysed using IBM© SPSS version 22. A descriptive analysis of sociodemographic characteristics, biophysical, biochemical and clinical profile was done. Inferential statistics on determinants of atherogenic index risk was performed using t-test and F-tests. These formed the basis for regression analyses (simple and binary). The levels of significance were set at 95% confidence interval (95% CI) while p-value of < 0.05 was set to be statistically significant. Table 1 shows the socio-demography and clinical profile of patients. The mean age of participants was 56±12 years. Patients within the age group 41-60 years constituted the majority (47.6%) of the study population while females predominate in all the age group except in those aged 40years with slightly lower proportion (49.0%). Majority (74.6%) were married and largely engaged in small business (49.2%).
RESULTS
Biochemically, only 23.0% of the patients whose blood samples were analysed for TC had desirable (normal) TC ( 5.2mmol/l) while majority 75.9% had high TC. However, 69.4% had desirable triglyceride, 49.5% and 78.5% had normal HDL-c and LDL respectively ( Table 1) .
Biophysical characteristics revealed that 3.7% of the patients were underweight with BMI <18.5 while over a quarter (36.9%) were overweight. Higher proportions of female participants were found to be overweight and obese accounting for 67.4% and 87.7% respectively. Similarly, higher proportions of females (55.7%) had uncontrolled BP than the males (44.3%).
Atherogenic risk: More than a quarter of participants (31.4%) had high atherogenic risk (> 0.24). Gender stratification shows that high atherogenicity was higher among female patients than males (60.0% and 40.0% respectively). Factors associated with atherogenic risk are as shown in table 2. Participants whose ages were 40years and 61years had higher proportions (40.8% and 33.6%) of high Atherogenic risk respectively, however, this association was not found to be statistically significant (p-value = 0.164). Furthermore, 28 
Informed consent and Ethics
Informed consent was obtained from eligible patients after explaining research concept to the patients in the language they best understand. Ethical approval for this study was obtained from the UITH Ethical Review Committee.
Data collection and analysis
Data was collected using Clinical Report Form (CRF) and a standardised questionnaire. The CRF was used to collect data on patients' medical information and records of parameters such as; BP, BMI, biochemical profile, disease history, drug history, complication and comorbidity history and hospital follow-up history. An interviewer-administered questionnaire was used to collect information on sociodemography.
Measurement
Physical Measurement: Blood pressure measurement, height and weight were measured as described by Riha et al (25) . Participants found to have systolic blood pressure 140mmHg and/or diastolic pressure 90mmHg were referred to as having poorly controlled hypertension. Participant categorization using BMI was as follows: BMI 18.5, "underweight," BMI 18.5-24.9, "normal weight," BMI 25-29.9, "overweight," and BMI 30, "obese". Laboratory Measurement: Participants underwent phlebotomy where blood samples for lipid profile (TC, TG, HDL-C, and LDLC) were collected. Blood samples were transported on the same day of collection to a central laboratory for processing and testing. Lipid profile analysis was done using the enzymatic colorimetric assay by the Cobas Integra 400 Plus©. Cut-off values for the different lipid parameters representative of dyslipidemia were as follows: TC >5.2mmol/L, TG >2.3mmol/L, LDLC >3.4mmol/L and HDL-C <1.04mmol/L for male, and <1.3mmol/L for female. Atherogenic risk profile, was categorized (27) . Similarly, study involving 52 countries spread across all continents (INTERHEART study), found that persons with history of myocardial infarction had three times the odds of having atherogenic dyslipidemia compared to persons without history of myocardial infarction (28) . Furthermore, an observational study done in Brazil found that persons with coronary disease had two times the odds of having an abnormal TG/HDL-C ratio (29) . Although not found to be statistically significant in this study, high serum glucose level was also associated with high atherogenic risk. Diabetes affects the integrity of the vasculature and is also associated with other conditions that predispose to CHD, such as hypertension and dyslipidemia that may explain the increased risk (4). Regression analyses revealed that the determinants of atherogenic risk were serum TG, HDL and serum LDL with significance at < 0.001. Participants with high TC were 1.64 times of having high atherogenic risk, while those with high LDL, overweight, obese, uncontrolled BP and high serum glucose were 1.43, 1.48, 1.34, 1.17 and 1.23 times of developing high atherogenic risk respectively. Previous epidemiological studies have shown that cholesterol, uncontrolled BP and serum glucose were predictors of CHD and LDL-C was associated with future risk (30) ; this is in tandem with our findings in this study. Similar to the Framingham and the INTERHEART studies (28, 30) obesity and overweight were associated with high atherogenic risk in this study population.
CONCLUSION
A significant proportion of participants in this study population are at risk of developing atherosclerosis. Persons with uncontrolled hypertension, dyslipidaemia and uncontrolled glycaemia, appear to be more at risk and may be considered as target groups for intervention programs. Follow-up studies are needed to further assess the risk among younger age group. Assessment of atherogenic index for all patients at risk of developing metabolic syndrome should be given due consideration by healthcare providers since it has been established to provide 0.048, < 0.001 and < 0.001 respectively). However, obesity, uncontrolled BP and high serum glucose among the study subjects were found not to be statistically significant. Tables 3 and 4 demonstrate regression analyses. Simple linear regression revealed that TG, HDL and LDL had linear relationship with high atherogenic risk as an independent entity with significance at < 0.001. For every unit increase of atherogenic index; there was a corresponding increase in the serum level of TG by 0.540 mmol/L, and 0.062mmol/L increase for LDL. Conversely, for every decrease in a unit of atherogenic index, there was a corresponding decrease in the serum level of (abnormal) HDL by -0.775mmol/l.
Predictors of high atherogenic risk on binary regression were TC, LDL, abnormal BMI (overweight and obese), uncontrolled BP and high serum glucose. Participants with high TC were 1.64 times of having high atherogenic risk, while those with high LDL, overweight, obese, uncontrolled BP and high serum glucose were 1.43, 1.48, 1.34, 1.17 and 1.23 times of developing high atherogenic risk respectively.
DISCUSSION
This study revealed that over threequarter of the patients being followed-up at UITH Ilorin, had hypercholesterolaemia (TC) while half of them had dyslipidaemia (low serum HDL) which was more pronounced among female patients. This implied increased risk of developing CHD and worsened medical outcome (4) . Similarly, large proportion of the study participants were obese and had uncontrolled BP despite being on treatment. These indicated inadequate treatment which could be multifactorial and corroborated findings from other studies that reported medical follow-up for hypertension in Nigeria. The study has established that both weight and uncontrolled BP are independent risks for CVD and CHD (4).
About a third (31.4%) of the participants had high atherogenic risk, of which females constituted majority (60%). This finding is higher compared to a similar study in Uganda where only a quarter had high atherogenic risk (4). Conversely, females were more at risk in our study than that of Ugandan study where males had higher risk. Almost half (49.5%) of the participants had uncontrolled BP with females being majority (55.7%) and the most likely explanation could be that females constituted the majority of the study population.
Factors that showed significant Atherogenic risk pattern among hypertension and diabetic patients Bolarinwa et al. 
